Chlamydia pneumoniae in Carotid Artery Atherosclerosis
- 1 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 33 (12) , 2756-2761
Abstract
Background and Purpose— There is growing clinical and experimental evidence that infections with Chlamydia pneumoniae might contribute to the development and progression of atherosclerosis. However, studies detecting the pathogen in atherosclerotic lesions examined either only atherosclerotic vessels or control vessels without atherosclerosis obtained from a different group of individuals. We analyzed atherosclerotic plaques of the carotid artery, samples of apparently healthy greater saphenous veins, and circulating leukocytes from the same individual patients for the presence of C pneumoniae . Methods— From each of 46 patients undergoing carotid endarterectomy for symptomatic carotid artery stenosis, these samples were analyzed by nested polymerase chain reaction for C pneumoniae –specific DNA. Furthermore, we determined IgA and IgG titers specific for the pathogen and plasma levels of C-reactive protein in these patients. Results— C pneumoniae DNA was detected in 86.9% of the leukocytes and in 82.6% of the atherosclerotic plaques but in only 6.5% of the saphenous veins. In 85% of patients who also had leukocytes positive for C pneumoniae , the atherosclerotic plaques were positive and the saphenous veins were negative. The presence of C pneumoniae –specific DNA in leukocytes significantly coincided with the presence of the respective DNA in the plaques of the carotid arteries ( P =0.0002). No association between the presence of C pneumoniae and specific IgA or IgG levels was seen. C-reactive protein levels were significantly higher in patients with chlamydia-positive atherosclerotic plaques and with positive leukocytes than in patients with negative plaques of the carotid arteries or negative leukocytes, respectively ( P P 80% incidence of C pneumoniae in atherosclerotic plaques of the carotid artery does not prove causality between an infection with the pathogen and the development of atherosclerosis. It must be emphasized, however, that >90% of apparently healthy saphenous veins were negative for C pneumoniae . Given the structural and functional differences between veins and arteries, careful interpretation of our results regarding a possible causative role of C pneumoniae seems warranted.Keywords
This publication has 30 references indexed in Scilit:
- Roxithromycin Treatment Prevents Progression of Peripheral Arterial Occlusive Disease in Chlamydia pneumoniae Seropositive MenCirculation, 2002
- Recent Strategies to Reduce Vein Graft Occlusion: a Need to Limit the Effect of Vascular DamageEuropean Journal of Vascular and Endovascular Surgery, 2002
- Comparison of Two Commercial Microimmunofluorescence Kits and an Enzyme Immunoassay Kit for Detection of Serum Immunoglobulin G Antibodies to Chlamydia pneumoniaeClinical and Diagnostic Laboratory Immunology, 2001
- Chlamydia pneumoniaein Atherosclerotic and Nonatherosclerotic TissueThe Journal of Infectious Diseases, 2000
- Chlamydia pneumoniaeDNA Detection in Peripheral Blood Mononuclear Cells Is Predictive of Vascular InfectionThe Journal of Infectious Diseases, 1999
- Detection of Chlamydia pneumoniae by colorimetric in situ hybridizationAPMIS, 1999
- Lack of association between prior infection with chlamydia pneumoniaeand acute or chronic coronary artery diseaseClinical Cardiology, 1999
- Induction of Interleukin‐12 Production in Chronic Hepatitis C Virus Infection Correlates with the Hepatocellular DamageThe Journal of Infectious Diseases, 1998
- Stranger in a strange land: The pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteriesProgress in Cardiovascular Diseases, 1991
- SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988